Literature DB >> 9801998

Dehydroepiandrosterone: dream or nightmare?

A Polleri, M V Gianelli, G Murialdo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9801998     DOI： 10.1007/BF03347343

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage.

Authors:  B Cheng; M P Mattson
Journal:  J Neurosci       Date:  1992-04       Impact factor: 6.167

2.  Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.

Authors:  F Labrie; A Bélanger; L Cusan; B Candas
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

Review 3.  Wishing a dream came true: DHEA as a rejuvenating treatment?

Authors:  O T Wolf; C Kirschbaum
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

4.  Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.

Authors:  P Diamond; L Cusan; J L Gomez; A Bélanger; F Labrie
Journal:  J Endocrinol       Date:  1996-09       Impact factor: 4.286

5.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

Authors:  A J Morales; J J Nolan; J C Nelson; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958
  5 in total
  2 in total

1.  Dehydroepiandrosterone replacement in elderly individuals: still waiting for the proof of beneficial effects on mood or memory.

Authors:  O T Wolf; C Kirschbaum
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 2.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.